Survivin expression in correlation with apoptotic activity in canine lymphomas

• Autorzy: Sokolowska J. , Urbanska K.
• Języki publikacji: EN

Abstrakty

EN

Survivin regulates cell cycle and mitosis and has antiapoptotic properties. Because of its dual function survivin has been the subject of much research focusing on its role in tumorigenesis and the relationship between survivin expression and apoptotic and/or proliferative activity in many types of human tumor including non-Hodgkin’s Lymphomas. Such studies have not been conducted in canine lymphomas. The aim of this study was to evaluate the expression of survivin in canine lymphomas of low (5/25) and high (20/25) grades in relation to apoptotic markers (apoptotic index and index of caspase-3). Survivin was found in all examined lymphomas. Most tumors (18/25) showed survivin expression in 10%-25% of positive cells. Only in single cases was lower (0-10% positive cells, 1/25) or higher (25%-50% and >50% positive cells, 5/25 and 1/25, respectively) survivin expression. No significant differences between mean values of either index of survivin or apoptotic index was found between low and high grade lymphomas. However, such a difference among lymphoma grades was shown regarding the caspase-3 index. No correlation between the survivin index and either the apoptotic index or caspase-3 index was found, irrespective of the method of quantification: in whole specimens or in areas of low and high survivin expression. Positive correlation was consistently noted only between both apoptotic markers. The results indicate that survivin is commonly expressed in canine lymphomas. It seems that survivin does not exhibit anti-apoptotic activity in canine lymphomas. Lack of correlation between survivin expression and apoptotic markers could indicate its potential role in cell cycle activation in lymphoma cells.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2017
• Tom: 20
• Numer: 2
• Opis fizyczny: p.329-338,fig.,ref.

Twórcy

autor

Sokolowska J.

• Department of Morphological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland

autor

Urbanska K.

• Department of Morphological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland

Bibliografia

• Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921.
• Ansell SM, Arendt BK, Grote DM, Jelinek DF, Novak AJ, Wellik LE, Remstein ED, Bennett CF, Fielding A (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin’s lymphoma. Leukemia 18: 616-623.
• Banks DP, Plescia J, Altieri DC, Chen J, Rosenberg SH, Zhang H, Ng SC (2000) Survivin does not inhibit caspase-3 activity. Blood 96: 4002-4003.
• de Graaf AO, van Krieken JH, Tönnissen E, Wissink W, van de Locht L, Overes I, Dolstra H, de Witte T, van der Reijden BA, Jansen JH (2005) Expression of C-IAP1, C-IAP2 and Survivin discriminates different types of lymphoid malignancies. Br J Haematol 130: 852-859.
• Fu DR, Kato D, Watabe A, Endo Y, Kadosawa T (2014) Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy. J Vet Med Sci 76: 1505-1512.
• Garg H, Suri P, Gupta JC, Talwar GP, Dubey S (2016) Survivin: a unique target for tumor therapy. Cancer Cell Int 16: 49.
• Grossman D, Kim PJ, Schechner JS, Altieri DC (2001) Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 98: 635-640.
• Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31: 1080-1085.
• Kuttler F, Valnet-Rabier MB, Angonin R, Ferrand C, Deconinck E, Mougin C, Cahn JY, Fest T (2002) Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin-cyclin B link. Leukemia 16: 726-735.
• Li F, Yang J, Ramnath N, Javle MM, Tan D (2005) Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 114: 509-512.
• Li J, Wu H (2006) Expression of survivin in human non-Hodgkin lymphoma and its correlation with proliferation and angiogenesis. J Huazhong Univ Sci Technolog Med Sci 26: 504-507.
• Lossos IS, Levy R (2003) Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 13: 191-202.
• Markovic O, Marisavljevic D, Cemerikic V, Perunicic M, Savic S, Filipovic B, Mihaljevic B (2011) Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL). Eur J Haematol 86: 246-255.
• Martinez A, Bellosillo B, Bosch F, Ferrer A, Marcé S, Villamor N, Ott G, Montserrat E, Campo E, Colomer D (2004) Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol 164: 501-510.
• Mellai M, Caldera V, Patrucco A, Annovazzi L, Schiffer D (2008) Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res 28: 109-118.
• Phillips BS, Kass PH, Naydan DK, Winthrop MD, Griffey SM, Madewell BR (2000) Apoptotic and proliferation indexes in canine lymphoma. J Vet Diagn Invest 12: 111-117.
• Ponce F, Marchal T, Magnol JP, Turinelli V, Ledieu D, Bonnefont C, Pastor M, Delignette ML, Fournel-Fleury C (2010) A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet Pathol 47: 414-433.
• Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH (2008) Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. J Vet Intern Med 22: 989-995.
• Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF, Guillou PJ (2002) Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer 86: 886-892.
• Shamsabadi FT, Eidgahi MR, Mehrbod P, Daneshvar N, Allaudin ZN, Yamchi A, Shahbazi M (2016) Survivin, a Promising Gene for Targeted Cancer Treatment. Asian Pac J Cancer Prev 17: 3711-3719.
• Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40: 1117-1123.
• Sokołowska J, Urbańska K, Giziński S, Wysocka A, Cywińska A, Lechowski R (2015) Survivin expression in canine lymphomas in relation with proliferative markers. Pol J Vet Sci 18: 113-122.
• Soleimanpour E, Babaei E (2015) Survivin as a Potential Target for Cancer Therapy. Asian Pac J Cancer Prev 16: 6187-6191.
• Symmans WF, Cangiarella JF, Symmans PJ, Cohen JM, Yee HT, Bennett G, Amorosi EL, Waisman J (2000) Apoptotic index from fine needle aspiration cytology as a criterion to predict histologic grade of non-Hodgkin’s lymphoma. Acta Cytol 44: 194-204.
• Tamura T, Said S, Lu W, Neufeld D (2000) Specificity of TUNEL method depends on duration of fixation. Biotech Histochem 75: 197-200.
• Tracey L, Peréz-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, PirisMA (2005) Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 206: 123-134.
• Zuo XL, Zhou X, Meng J, Zhang KJ, Liu XH, Yang HQ (2006) A study on the expression of myeloid cell leukemia 1 proteins and survivin and their relation with B cell apoptosis in non-Hodgkin’s lymphoma. Zhonghua Nei Ke Za Zhi 45: 133-135.
• Zuo XL, Zhou Y, Zhou X, Liu XH, Zhang KJ, Yang HQ, Meng J (2007) Expression of survivin and P63 protein in B cell non-Hodgkin’s lymphoma and their effects on cell apoptosis and proliferation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15: 99-102.
• Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW (2002) DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 303: 124-131.

Identyfikatory

DOI

10.1515/pjvs-2017-0040